Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOLRIAMFETOL vs SORAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SOLRIAMFETOL vs SORAFENIB: Safety Overview

Metric SOLRIAMFETOL SORAFENIB
Total FAERS Reports 2,135 10,908
Deaths Reported 9 2,489
Death Rate 0.4% 22.8%
Hospitalizations 75 3,547
Average Patient Age 43.2 yrs 61.1 yrs
% Female Patients 71.4% 29.5%
FDA Approval Date Jun 17, 2019 Apr 12, 2023
Manufacturer Axsome Therapeutics, Inc. Upsher-Smith Laboratories, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription